tiprankstipranks
Advertisement
Advertisement

HK:2005 Stock Latest News

SSY Group Wins NMPA Approvals for New Electrolyte and Antiemetic Injections
Company AnnouncementsSSY Group Wins NMPA Approvals for New Electrolyte and Antiemetic Injections
5d ago
SSY Group Wins China Approval for Upadacitinib Bulk Drug
PremiumCompany Announcements
SSY Group Wins China Approval for Upadacitinib Bulk Drug
16d ago
SSY Group Wins China Approval for New Irrigation and Bumetanide Injectables
PremiumCompany Announcements
SSY Group Wins China Approval for New Irrigation and Bumetanide Injectables
19d ago
SSY Group Profit Halves as Revenue and Margins Slide in Challenging 2025
PremiumCompany Announcements
SSY Group Profit Halves as Revenue and Margins Slide in Challenging 2025
19d ago
SSY Group Declares Final Cash Dividend of HKD 0.03 per Share for 2025
PremiumCompany Announcements
SSY Group Declares Final Cash Dividend of HKD 0.03 per Share for 2025
19d ago
SSY Group Wins China Approval for Calcium Chloride Bulk Drug
PremiumCompany AnnouncementsSSY Group Wins China Approval for Calcium Chloride Bulk Drug
27d ago
SSY Group Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
SSY Group Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
29d ago
SSY Group Wins China Approval for Bumetanide Bulk Drug
Premium
Company Announcements
SSY Group Wins China Approval for Bumetanide Bulk Drug
1M ago
SSY Group Wins First PRC Approval for New Fat-Soluble Vitamin Injection
PremiumCompany Announcements
SSY Group Wins First PRC Approval for New Fat-Soluble Vitamin Injection
1M ago
SSY Group Wins China Approval for Homegrown High-Performance Infusion Tubing
PremiumCompany Announcements
SSY Group Wins China Approval for Homegrown High-Performance Infusion Tubing
1M ago
SSY Group Wins China Approval for New Oncology Injection
PremiumCompany Announcements
SSY Group Wins China Approval for New Oncology Injection
1M ago
SSY Group Wins First-in-China Approval for Doxapram Injection
PremiumCompany Announcements
SSY Group Wins First-in-China Approval for Doxapram Injection
1M ago
SSY Group Wins Hebei Approval for Gynecological Gel and Heart Failure Test Kit
PremiumCompany AnnouncementsSSY Group Wins Hebei Approval for Gynecological Gel and Heart Failure Test Kit
2M ago
SSY Group Wins NMPA Approval for Metoclopramide Bulk Drugs
Premium
Company Announcements
SSY Group Wins NMPA Approval for Metoclopramide Bulk Drugs
2M ago
SSY Group Issues Profit Warning as Pricing and Demand Pressures Hit 2025 Earnings
Premium
Company Announcements
SSY Group Issues Profit Warning as Pricing and Demand Pressures Hit 2025 Earnings
2M ago
SSY Group Wins China Approval for Propranolol Bulk Drug
PremiumCompany Announcements
SSY Group Wins China Approval for Propranolol Bulk Drug
2M ago
SSY Group Wins 45 Drug Selections in China’s National Centralised Procurement Renewal
PremiumCompany Announcements
SSY Group Wins 45 Drug Selections in China’s National Centralised Procurement Renewal
2M ago
SSY Group Wins NMPA Approvals for Two New Bulk Drug Products
PremiumCompany Announcements
SSY Group Wins NMPA Approvals for Two New Bulk Drug Products
2M ago
SSY Group Wins NMPA Approval for New Cardiac Injection
PremiumCompany Announcements
SSY Group Wins NMPA Approval for New Cardiac Injection
3M ago
SSY Group Wins China Approval for New Specification of Nutritional Injection
PremiumCompany AnnouncementsSSY Group Wins China Approval for New Specification of Nutritional Injection
3M ago
SSY Group Wins China Approval for New Hypertension Combination Drug
Premium
Company Announcements
SSY Group Wins China Approval for New Hypertension Combination Drug
3M ago
SSY Group Wins NMPA Approval for Sodium Glycerophosphate Injection
Premium
Company Announcements
SSY Group Wins NMPA Approval for Sodium Glycerophosphate Injection
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >